Tags

Type your tag names separated by a space and hit enter

COVID-19 vaccine effectiveness in patients with non-dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada.
Kidney Int. 2022 12; 102(6):1420-1423.KI

Authors+Show Affiliations

BC Renal, Vancouver, British Columbia, Canada. Electronic address: matiquzzaman@bcpra.ubc.ca.BC Renal, Vancouver, British Columbia, Canada.BC Renal, Vancouver, British Columbia, Canada.BC Renal, Vancouver, British Columbia, Canada; Provincial Health Services Authority, Vancouver, British Columbia, Canada.School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.BC Centre for Disease Control, Vancouver, British Columbia, Canada.Data and Decision Sciences, Ontario Health, Toronto, Ontario, Canada.Ontario Renal Network, Toronto, Ontario, Canada.Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.BC Renal, Vancouver, British Columbia, Canada; Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.

Pub Type(s)

Observational Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

36103954

Citation

Atiquzzaman, Mohammad, et al. "COVID-19 Vaccine Effectiveness in Patients With Non-dialysis-dependent Chronic Kidney Diseases: Findings From a Population-based Observational Study From British Columbia, Canada." Kidney International, vol. 102, no. 6, 2022, pp. 1420-1423.
Atiquzzaman M, Zheng Y, Er L, et al. COVID-19 vaccine effectiveness in patients with non-dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada. Kidney Int. 2022;102(6):1420-1423.
Atiquzzaman, M., Zheng, Y., Er, L., Djurdjev, O., Singer, J., Krajden, M., Balamchi, S., Thomas, D., Oliver, M. J., & Levin, A. (2022). COVID-19 vaccine effectiveness in patients with non-dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada. Kidney International, 102(6), 1420-1423. https://doi.org/10.1016/j.kint.2022.08.027
Atiquzzaman M, et al. COVID-19 Vaccine Effectiveness in Patients With Non-dialysis-dependent Chronic Kidney Diseases: Findings From a Population-based Observational Study From British Columbia, Canada. Kidney Int. 2022;102(6):1420-1423. PubMed PMID: 36103954.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 vaccine effectiveness in patients with non-dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada. AU - Atiquzzaman,Mohammad, AU - Zheng,Yuyan, AU - Er,Lee, AU - Djurdjev,Ognjenka, AU - Singer,Joel, AU - Krajden,Mel, AU - Balamchi,Shabnam, AU - Thomas,Doneal, AU - Oliver,Matthew J, AU - Levin,Adeera, Y1 - 2022/09/11/ PY - 2022/05/05/received PY - 2022/08/03/revised PY - 2022/08/19/accepted PY - 2022/9/15/pubmed PY - 2022/11/24/medline PY - 2022/9/14/entrez KW - COVID-19 KW - PROMIS KW - chronic kidney disease KW - vaccine effectiveness SP - 1420 EP - 1423 JF - Kidney international JO - Kidney Int VL - 102 IS - 6 SN - 1523-1755 UR - https://www.unboundmedicine.com/medline/citation/36103954/COVID_19_vaccine_effectiveness_in_patients_with_non_dialysis_dependent_chronic_kidney_diseases:_findings_from_a_population_based_observational_study_from_British_Columbia_Canada_ DB - PRIME DP - Unbound Medicine ER -